Previous close | 134,200.00 |
Open | 133,700.00 |
Bid | 135,100.00 x 0 |
Ask | 138,700.00 x 0 |
Day's range | 133,700.00 - 137,700.00 |
52-week range | 119,500.00 - 230,000.00 |
Volume | |
Avg. volume | 38,981 |
Market cap | 12.329T |
Beta (5Y monthly) | 0.78 |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | 5,050.00 (3.74%) |
Ex-dividend date | 29 Mar 2024 |
1y target est | N/A |
SK E&S has collaborated with global partners to establish foundation for the domestic low-carbon hydrogen* industry, with support from local government. They plan to mass-produce low-carbon hydrogen, leading the early establishment of the domestic hydrogen ecosystem and contributing to global carbon neutrality.
SK pharmteco will participate at the CPHI 2023 in Barcelona and prepare a dedicated booth at the event. As a multi-modality CDMO with expertise in small molecule active pharmaceutical ingredients (APIs) and biopharmaceuticals, SK pharmteco aims to present its business competitiveness and actively pursue business opportunities.